Russian consensus: balloon pulmonary angioplasty in treatment of chronic thromboembolic pulmonary hypertension

For a long time, the only method of revascularization in patients with chronic thromboembolic pulmonary hypertension (CTEPH) was pulmonary thromboendarterectomy from the branches of pulmonary artery. Transluminal balloon pulmonary angioplasty (BPA), as an alternative treatment option for inoperable and residual CTEPH, appeared recently, but has already firmly taken its place in the treatment algorithm of CTEPH, and has significantly improved the prognosis in such patients. Active use of BPA in everyday practice served as the reason for the creation of this consensus in order to summarize and systematize modern data on patient selection, technique and goals of endovascular treatment, prevention and treatment of complications. The document additionally covers the issues of visualization of the pulmonary arteries, complex variants of damage and describes an algorithm for the prevention and treatment of pulmonary injury after BPA. The recommendations provided in the consensus are based on the results of national and foreign studies, the experience of experts and are intended for specialists who are part of a multidisciplinary team for the management of patients with CTEPH (cardiologists, endovascular and cardiovascular surgeons), as well as pulmonologists, radiation diagnosticians and physicians.

1. Chazova I.E., Martynyuk T.V., Shmalts A.A. et al. Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension (2023). Eurasian heart journal. 2024;(1):6-85. (In Russ.). https://doi.org/10.38109/2225-1685-2024-1-6-85]

2. Humbert M., Kovacs G., Hoeper M.M. et al. ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2023 Jan 6;61(1):2200879. https://doi.org/10.1183/13993003.00879-2022

3. Avdeev S.N., Barbarash O.L., Valieva Z.S. et al. 2024 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension. Russian Journal of Cardiology. 2024;29(11):6161. (In Russ.). https://doi.org/10.15829/1560-4071-2024-6161

4. Simonneau G., Montani D., Celermajer D.S. et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019 Jan 24;53(1):1801913. https://doi.org/10.1183/13993003.01913-2018

5. Klok F.A., Surie S., Kempf T., et al. A simple non-invasive diagnostic algorithm for ruling out chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Thromb Res 2011;128:21-26. https://doi.org/10.1016/j.thromres.2011.03.004

6. Guerin L., Couturaud F., Parent F., et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism. Thromb Haemost 2014;112:598-605. https://doi.org/10.1160/th13-07-0538

7. Valerio L. Mavromanoli A.C., Barco S. et al. Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study. Eur Heart J. 2022 Sep 21;43(36):3387-3398. https://doi.org/10.1093/eurheartj/ehac206

8. Avdeev S.N., Barbarash O.L., Bautin A.E., et al. 2020 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension. Russian Journal of Cardiology. 2021;26(12):4683. (In Russ.). https://doi.org/10.15829/1560-4071-2021-4683

9. Lang I.M., Dorfmüller P, Vonk Noordegraaf A. The Pathobiology of Chronic Thromboembolic Pulmonary Hypertension. Ann Am Thorac Soc. 2016 Jul;13 Suppl 3:S215-21. https://doi.org/10.1513/annalsats.201509-620as

10. Kim N.H. Group 4 Pulmonary Hypertension: Chronic Thromboembolic Pulmonary Hypertension: Epidemiology, Pathophysiology, and Treatment. Cardiol Clin. 2016 Aug;34(3):435- 41. https://doi.org/10.1016/j.ccl.2016.04.011

11. Lang I.M., Pesavento R., Bonderman D., Yuan J.X. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J. 2013 Feb;41(2):462-8. https://doi.org/10.1183/09031936.00049312

12. Moser K.M., Bloor C.M. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest. 1993 Mar;103(3):685-92. https://doi.org/10.1378/chest.103.3.685

13. Dorfmüller P., Günther S., Ghigna M.R. et al. Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature. Eur Respir J. 2014 Nov;44(5):1275-88. https://doi.org/10.1183/09031936.00169113

14. Simonneau G., Torbicki A., Dorfmüller P., Kim N. The pathophysiology of chronic thromboembolic pulmonary hypertension. Eur Respir Rev 2017; 26(143):160112. https://doi.org/10.1183/16000617.0112-2016

15. Pepke-Zaba J., Delcroix M., Lang I., et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011 Nov 1;124(18):1973-81. https://doi.org/10.1161/circulationaha.110.015008

16. Guth S., D'Armini A.M., Delcroix M. et al.Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry. ERJ Open Res. 2021 Aug 16;7(3):00850-2020. https://doi.org/10.1183/23120541.00850-2020

17. Danilov N.M., Matchin Y.G., Chernyavsky A.M. et al. Balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension // Terapevticheskii arkhiv. 2019;91(4):43-47. (In Russ.). https://doi.org/10.26442/00403660.2019.04.000100]

18. Danilov, N.M., Matchin, Y.G., Yarovoy, S.Y. et al. TCT-92 Short-and Long-Term Remodeling of Pulmonary Arteries After Balloon Angioplasty in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension. Journal of the American College of Cardiology. 2016:68(18):B37-B38. https://doi.org/10.1016/j.jacc.2016.09.365

19. Jain N., Sheikh M.A., Bajaj D. et al. Periprocedural Complications With Balloon Pulmonary Angioplasty: Analysis of Global Studies. JACC Cardiovasc Interv. 2023 Apr 24;16(8):976-983. https://doi.org/10.1016/j.jcin.2023.01.361

20. Hyder S.N., Chatterjee S., Aggarwal V. Percutaneous Treatments for Pulmonary Hypertension: Reviewing the Growing Procedural Role for Interventional Cardiology. Interv Cardiol Clin. 2022 Jul;11(3):293-305. https://doi.org/10.1016/j.iccl.2022.01.006

21. Mizoguchi H., Ogawa A., Munemasa M. et al. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012 Dec;5(6):748- 55. https://doi.org/10.1161/circinterventions.112.971077

22. Provost M., Mornex J.F., Nasser M. et al. Changes in the management of chronic thromboembolic pulmonary hypertension over a 10-year period, in a French expert regional competence centre. Respir Med Res. 2023 Nov;84:101021. https://doi.org/10.1016/j.resmer.2023.101021

23. Chazova I.E., Karabasheva M.B., Danilov N.M., Matchin Yu.G. Chronic thromboembolic pulmonary hypertension: modern view on the problem. Russian Cardiology Bulletin. 2019;14(2):1423. (In Russ.). https://doi.org/10.17116/Cardiobulletin20191402114]

24. Danilov N.M., Yarovoy S.Yu., Elfimova E.M., Mikhailova O.O., Litvin A.Yu., Danilushkin Yu.V., Matchin Yu.G., Chazova I.E. Clinical and radiological aspects of reperfusion pulmonary edema after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Systemic Hypertension. 2022;19(3):23- 30. (In Russ.). https://doi.org/10.38109/2075-082X-2022-3-23-30

25. Elfimova E.M., Danilov N.M., Yarovoy S.Yu., Mikhailova O.O., Litvin A.Yu., Matchin Yu.G., Chazova I.E. Effect of CPAP therapy on the reperfusion lung injury after transluminal balloon angioplasty of the pulmonary arteries in patients with chronic thromboembolic pulmonary hypertension. Systemic Hypertension. 2023;20(3):11-18. (In Russ.) https://doi.org/10.38109/2075-082X-2023-3-11-18

26. Riedel M., Stanek V., Widimsky J., Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest. 1982 Feb;81(2):151-8. https://doi.org/10.1378/chest.81.2.151

27. Lewczuk J., Piszko P., Jagas J. et al. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest. 2001 Mar;119(3):818-23. https://doi.org/10.1378/chest.119.3.818

28. Kunieda T., Nakanishi N., Satoh T. et al. Prognoses of primary pulmonary hypertension and chronic majorvessel thromboembolic pulmonary hypertension determined from cumulative survival curves. Intern Med. 1999 Jul;38(7):543-6. https://doi.org/10.2169/internalmedicine.38.543

29. Hoeper M.M., Mayer E., Simonneau G., Rubin L.J. Chronic thromboembolic pulmonary hypertension. Circulation. 2006 Apr 25;113(16):2011-20. https://doi.org/10.1161/circulationaha.105.602565

30. Mayer E., Jenkins D., Lindner J. et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011 Mar;141(3):702-10. https://doi.org/10.1016/j.jtcvs.2010.11.024

31. van der Plas M.N., Surie S., Reesink H.J. et al. Longitudinal follow-up of six-minute walk distance after pulmonary endarterectomy. Ann Thorac Surg. 2011 Apr;91(4):1094-9. https://doi.org/10.1016/j.athoracsur.2010.11.061

32. Condliffe R., Kiely D.G., Gibbs J.S. et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008 May 15;177(10):1122-7. https://doi.org/10.1164/rccm.200712-1841oc

33. Jamieson S.W., Kapelanski D.P., Sakakibara N. et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003 Nov;76(5):1457-62; discussion 1462-4. https://doi.org/10.1016/s0003-4975(03)00828-2

34. Cannon J.E., Su L., Kiely D.G. et al. Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort. Circulation. 2016 May 3;133(18):1761-71. https://doi.org/10.1161/circulationaha.115.019470

35. Inami T., Kataoka M., Ando M. et al. A new era of therapeutic strategies for chronic thromboembolic pulmonary hypertension by two different interventional therapies; pulmonary endarterectomy and percutaneous transluminal pulmonary angioplasty. PLoS One. 2014 Apr 11;9(4):e94587. https://doi.org/10.1371/journal.pone.0094587

36. Voorburg J.A., Cats V.M., Buis B., Bruschke A.V. Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism. Chest. 1988 Dec;94(6):1249-53. https://doi.org/10.1378/chest.94.6.1249

37. Feinstein J.A., Goldhaber S.Z., Lock J.E. et al. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation. 2001 Jan 2;103(1):10-3. https://doi.org/10.1161/01.cir.103.1.10

38. Inami T., Kataoka M., Shimura N. et al. Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty. JACC Cardiovasc Interv. 2013 Jul;6(7):725-36. https://doi.org/10.1016/j.jcin.2013.03.009

39. Tsuji A., Ogo T., Demachi J. et al. Rescue balloon pulmonary angioplasty in a rapidly deteriorating chronic thromboembolic pulmonary hypertension patient with liver failure and refractory infection. Pulm Circ. 2014 Mar;4(1):142-7. https://doi.org/10.1086/675643

40. Taniguchi Y., Miyagawa K., Nakayama K. et al. Balloon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension. EuroIntervention. 2014 Aug;10(4):518-25. https://doi.org/10.4244/eijv10i4a89

41. Andreassen A.K., Ragnarsson A., Gude E. et al. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart. 2013 Oct;99(19):1415-20. https://doi.org/10.1136/heartjnl-2012-303549

42. Sugimura K., Fukumoto Y., Satoh K.et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J. 2012;76(2):485- 8. https://doi.org/10.1253/circj.cj-11-1217

43. Danilov N.M., Matchin Y.G., Martynyuk T.V. et al. Transluminal balloon angioplasty of pulmonary arteries in patients with inoperable chronic thromboembolic pulmonary hypertension (first experience in Russia). Consilium Medicum. 2015; 17 (10): 61–66. (In Russ.). https://doi.org/10.26442/2075-1753_2015.10.61-66]

44. Galiè N., Humbert M., Vachiery J.L. ESC Scientific Document Group. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016 Jan 1;37(1):67-119. https://doi.org/10.1093/eurheartj/ehv317

45. Fukuda K., Date H., Doi S. et al. Japanese Circulation Society and the Japanese Pulmonary Circulation and Pulmonary Hypertension Society Joint Working Group. Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017). Circ J. 2019 Mar 25;83(4):842-945. https://doi.org/10.1253/circj.cj-66-0158

46. Kataoka M., Inami T., Kawakami T. et al. Balloon Pulmonary Angioplasty (Percutaneous Transluminal Pulmonary Angioplasty) for Chronic Thromboembolic Pulmonary Hypertension: A Japanese Perspective. JACC Cardiovasc Interv. 2019 Jul 22;12(14):1382- 1388. https://doi.org/10.1016/j.jcin.2019.01.237

47. Chazova I.E., Martynyuk T.V., Vasileva Z.S. et al. Eurasian guidelines for the diagnosis and treatment of CTEPH (2020). Eurasian heart journal. 2021;(1):6-43. (In Russ.). https://doi.org/10.38109/2225-1685-2021-1-6-43]

48. Kawakami T., Matsubara H., Shinke T. et al. Balloon pulmonary angioplasty versus riociguat in inoperable chronic thromboembolic pulmonary hypertension (MR BPA): an open-label, randomised controlled trial. Lancet Respir Med. 2022 Oct;10(10):949-960. https://doi.org/10.1016/s2213-2600(22)00171-0

49. Jaïs X., Brenot P., Bouvaist H. et al. Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study. Lancet Respir Med. 2022 Oct;10(10):961-971. https://doi.org/10.1016/s2213-2600(22)00214-4

50. Thistlethwaite P.A., Mo M., Madani M.M. et al. Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg. 2002 Dec;124(6):1203-11. https://doi.org/10.1067/mtc.2002.127313

51. Madani M.M. Surgical Treatment of Chronic Thromboembolic Pulmonary Hypertension: Pulmonary Thromboendarterectomy. Methodist Debakey Cardiovasc J. 2016 Oct-Dec;12(4):213-218. https://doi.org/10.14797/mdcj-12-4-213

52. Kawakami T., Ogawa A., Miyaji K. et al.. Novel Angiographic Classification of Each Vascular Lesion in Chronic Thromboembolic Pulmonary Hypertension Based on Selective Angiogram and Results of Balloon Pulmonary Angioplasty. Circ Cardiovasc Interv. 2016 Oct;9(10):e003318. https://doi.org/10.1161/circinterventions.115.003318

53. Demchenkova A.Yu., Veselova T.N., Martynyuk T.V. et al. The State of Vascular Bed, Parenchyma and Perfusion of Lungs in Chronic Thromboembolic Pulmonary Hypertension According to Data of Subtraction Pulmonary Angiography. Kardiologiia. 2018;58(5):48- 56. (In Russ.). https://doi.org/10.18087/cardio.2018.5.10120]

54. Ghani H., Weir-McCall J.R., Ruggiero A., Pepke-Zaba J. Imaging in chronic thromboembolic pulmonary disease: Current practice and advances. Int J Cardiol Congenit Heart Dis. 2024 Aug 10;17:100536. https://doi.org/10.1016/j.ijcchd.2024.100536

55. Hinrichs J.B., Renne J., Hoeper M.M. et al. Balloon pulmonary angioplasty: applicability of C-Arm CT for procedure guidance. Eur Radiol. 2016 Nov;26(11):4064-4071. https://doi.org/10.1007/s00330-016-4280-z

56. NOMENCLATURE of broncho-pulmonary anatomy; an international nomenclature accepted by the Thoracic Society. Thorax. 1950 Sep;5(3):222-8. https://doi.org/10.1136/thx.5.3.222

57. Lang I.M., Andreassen A.K., Andersen A. et al. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function. Eur Heart J. 2023 Aug 1;44(29):2659-2671. https://doi.org/10.1093/eurheartj/ehad413

58. Shimokawahara H., Ogawa A., Mizoguchi H. et al. Vessel Stretching Is a Cause of Lumen Enlargement Immediately After Balloon Pulmonary Angioplasty: Intravascular Ultrasound Analysis in Patients With Chronic Thromboembolic Pulmonary Hypertension. Circ Cardiovasc Interv. 2018 Apr;11(4):e006010. https://doi.org/10.1161/circinterventions.117.006010

59. Räber L., Ueki Y., Lang I.M. Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. EuroIntervention. 2019 Oct 4;15(9):e814-e815. https://doi.org/10.4244/eij-d-18-01212

60. Danilov N.M., Matchin Yu.G., Sagaydak O.V. et al. Antecubital vein access for balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: safe new approach. Russian Open Medical Journal 2019; 8: e0107. https://doi.org/10.15275/rusomj.2019.0107

61. Roik M., Wretowski D., Rowiński O. et al. Refined balloon pulmonary angioplasty in inoperable chronic thromboembolic pulmonary hypertension--a multi-modality approach to the treated lesion. Int J Cardiol. 2014 Dec 20;177(3):e139-41. https://doi.org/10.1016/j.ijcard.2014.09.051

62. Roik M., Wretowski D., Łabyk A. et al. Refined balloon pulmonary angioplasty driven by combined assessment of intra-arterial anatomy and physiology--Multimodal approach to treated lesions in patients with non-operable distal chronic thromboembolic pulmonary hypertension--Technique, safety and efficacy of 50 consecutive angioplasties. Int J Cardiol. 2016 Jan 15;203:228-35. https://doi.org/10.1016/j.ijcard.2015.10.116

63. Banning A.P., Serruys P., De Maria G.L. et al. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study. Eur Heart J. 2022 Mar 31;43(13):1307-1316. https://doi.org/10.1093/eurheartj/ehab703

64. Gerges C., Friewald R., Gerges M. et al. Efficacy and Safety of Percutaneous Pulmonary Artery Subtotal Occlusion and Chronic Total Occlusion Intervention in Chronic Thromboembolic Pulmonary Hypertension. Circ Cardiovasc Interv. 2021 Aug;14(8):e010243. https://doi.org/10.1161/circinterventions.120.010243

65. Tajti P., Karmpaliotis D., Alaswad K., et al. The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: Update From the PROGRESS CTO Registry. JACC Cardiovasc Interv. 2018 Jul 23;11(14):1325-1335. https://doi.org/10.1016/j.jcin.2018.02.036

66. Galassi A.R., Werner G.S., Boukhris M. et al. Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club. EuroIntervention. 2019 Jun 20;15(2):198-208. https://doi.org/10.4244/eij-d-18-00826

67. Steinberg Z.L., Lombardi W.L., Lee J. et al. Balloon Pulmonary Angioplasty in Chronic Totally Occluded Pulmonary Arteries: Applying Lessons Learned From the Treatment of Coronary Artery Chronic Total Occlusions. J Invasive Cardiol. 2021 Aug;33(8):E632-E639. https://doi.org/10.25270/jic/20.00623

68. Kurzyna M., Darocha S., Pietura R., et al. Changing the strategy of balloon pulmonary angioplasty resulted in a reduced complication rate in patients with chronic thromboembolic pulmonary hypertension. A single-centre European experience. Kardiol Pol. 2017;75:645-654. Epub 2017 May 29. https://doi.org/10.5603/kp.a2017.0091

69. Marukyan N., Simakova M., Moiseeva O., Kashtanov M. Transbronchial Guidance for Balloon Pulmonary Angioplasty in CTEPH: The Safe Guidewire Passage Through the Occlusion. JACC Cardiovasc Interv. 2022 Jan 24;15(2):e25-e26. https://doi.org/10.1016/j.jcin.2021.11.006

70. Rathore S., Katoh O., Matsuo H. et al. Retrograde percutaneous recanalization of chronic total occlusion of the coronary arteries: procedural outcomes and predictors of success in contemporary practice. Circ Cardiovasc Interv. 2009 Apr;2(2):124-32. https://doi.org/10.1161/circinterventions.108.838862

71. Marukyan N., Zubarev D., Gorbatykh A., et al. Carlino-Like Technique for Retrograde Recanalization of Chronic Thromboembolic Pulmonary Artery Occlusion. JACC Cardiovasc Interv. 2024 Jun 10;17(11):1394-1396. https://doi.org/10.1016/j.jcin.2024.01.308

72. Valieva Z.S., Martynyuk T.V. Choice of specific and anticoagulant therapy in patients with newly diagnosed chronic thromboembolic pulmonary hypertension, depending on operability status. Russian Journal of Cardiology. 2023;28(3):5231. (In Russ.). https://doi.org/10.15829/1560-4071-2023-5231

73. Delcroix M., Torbicki A., Gopalan D. et al. ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J 2021; 57(6):2002828. https://doi.org/10.1183/13993003.02828-2020

74. Stickel S., Gin-Sing W., Wagenaar M, Gibbs J.S.R. The practical management of fluid retention in adults with right heart failure due to pulmonary arterial hypertension. Eur Heart J Suppl. 2019 Dec;21(Suppl K):K46-K53. https://doi.org/10.1093/eurheartj/suz207

75. Dinevich E.O., Danilov N.M., Chazova I.E. The role of soluble guanylate cyclase stimulator riociguat in preventing the development of reperfusion lung injury after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Systemic Hypertension. 2023;20(4):11-17. (In Russ.). https://doi.org/10.38109/2075-082X-2023-4-11-17]

76. Karabasheva M.B., Danilov N.M., Sagaidak O.V., Matchin Y.G., Chazova I.E. Long-term outcomes after percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Systemic Hypertension. 2019;16(4):27-32. (In Russ.). https://doi.org/10.26442/2075082X.2019.4.190609

77. Shigetoshi M., Hatanaka K., Ogawa A., et al. Oxygen inhalation can selectively dilate pulmonary arteries in patients with chronic thromboembolic pulmonary hypertension before balloon angioplasty. J Cardiol. 2022 Feb;79(2):265-269. https://doi.org/10.1016/j.jjcc.2021.09.003

78. Nef H.M., Achenbach S., Birkemeyer R. et al. Manual der arbeitsgruppe interventionelle kardiologie (AGIK) der deutschen gesellschaft für kardiologie—herz-und kreislaufforschung e. V. (DGK). Der Kardiologe Volume 2021;15:542–584. https://doi.org/10.1007/s12181-021-00504-6

79. Sebastià C., Nicolau C., Martín de Francisco Á.L. et al. Prophylaxis against postcontrast acute kidney injury (PC-AKI): updates in the ESUR guidelines 10.0 and critical review. Radiologia (Engl Ed). 2020 Jul-Aug;62(4):292-297. English, Spanish. https://doi.org/10.1016/j.rx.2019.12.005

80. Guideline] ACR Committee on Drugs and Contrast Media. ACR Manual on Contrast Media 2023. American College of Radiology. Available at https://www.acr.org/-/media/acr/files/clinical-resources/contrast_media.pdf.

81. Arzhantsev A.S., Danilov N.M., Atanesyan R.V. et al. Perforation of pulmonary arteries during transluminal balloon angioplasty. Russian Cardiology Bulletin. 2021;16(1):5663. (In Russ.). https:// doi.org/10.17116/Cardiobulletin20211601156

82. Aggarwal V., Giri J., Visovatti S.H. et al. Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association. Circulation. 2024 Apr 9;149(15):e1090-e1107. https://doi.org/10.1161/cir.0000000000001197

83. Christoph B. Wiedenroth, Henrike Deissner, Miriam S.D. et al. Complications of balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: Impact on the outcome, The Journal of Heart and Lung Transplantation. 2022 AUG;41(8):1086-1094. EPUB 2022 MAY 20. PMID: 35690560. https://doi.org/10.1016/J.HEALUN.2022.05.002

84. Velazquez M., Albarran A., Hernandez I. et al. Balloon Pulmonary Angioplasty for Inoperable Patients With Chronic Thromboembolic Pulmonary Hypertension. Observational Study in a Referral Unit. Rev Esp Cardiol (Engl Ed). 2019 Mar;72(3):224-232. https://doi.org/10.1016/j.rec.2018.02.020

85. Correction to: Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association. Circulation. 2024 Jun 11;149(24):e1412. https://doi.org/10.1161/cir.0000000000001261

86. Ogo T., Fukuda T., Tsuji A. et al. Efficacy and safety of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension guided by cone-beam computed tomography and electrocardiogram-gated area detector computed tomography. Eur J Radiol. 2017 Apr;89:270-276. https://doi.org/10.1016/j.ejrad.2016.12.013

87. Mahmud E., Ang L. Time to Standardize Definitions for the Success and Complications of Balloon Pulmonary Angioplasty: A Quality Imperative. JACC Cardiovasc Interv. 2023 Apr 24;16(8):984-985. https://doi.org/10.1016/j.jcin.2023.02.017

88. Elfimova E.M., Danilov N.M., Yarovoy S.Yu. et al. Effect of CPAP therapy on the reperfusion lung injury after transluminal balloon angioplasty of the pulmonary arteries in patients with chronic thromboembolic pulmonary hypertension. Systemic Hypertension. 2023;20(3):11-18. (In Russ.). https://doi.org/10.38109/2075-082X-2023-3-11-18]

89. Brenot P., Jais X., Taniguchi Y. et al. French Experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Eur Respir J 2019;53:1802095. https://doi.org/10.1183/13993003.02095-2018

90. Methodological recommendations “Non-invasive ventilation”, All-Russian public organization Federation of Anesthesiologists and Resuscitators, 2020. https://faronline.ru/api/static/cms-files/53189cb3-1fb2-469a-ad9c-e44a537158e2/niv2020.pdf

91. Shinkura Y., Nakayama K., Yanaka K. et al. Extensive revascularisation by balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension beyond haemodynamic normalisation. EuroIntervention. 2018 Apr 20;13(17):2060-2068. https://doi.org/10.4244/eij-d-17-00157

92. Chronic thromboembolic pulmonary hypertension surgery. Chernyavskiy AM. Novosibirsk. Siberian Branch of the Russian Academy of Sciences, 2019. – 318 pp (In Russ.)

93. Wilkens H., Konstantinides S., Lang I.M., et al. Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018. Int J Cardiol. 2018;272S:69-78. https://doi.org/10.1016/j.ijcard.2018.08.079

94. Badoyan A.G., Grankin D.S., Krestyaninov O.V., Sharafutdinov U.Sh., Manukyan S.N., Baranov A.A., Khelimsky D.A. Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: immediate and long-term results. Circulatory pathology and cardiac surgery. 2024;28(3):52-63. (In Russ.) https://doi.org/10.21688/1681-3472-2024-3-52-63

95. Delcroix M., Pepke-Zaba J., D'Armini A.M. et al. Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy. Circulation. 2024 Oct 22;150(17):1354-1365. https://doi.org/10.1161/circulationaha.124.068610

96. Araszkiewicz A., Darocha S., Pietrasik A. et al. Balloon pulmonary angioplasty for the treatment of residual or recurrent pulmonary hypertension after pulmonary endarterectomy. Int J Cardiol. 2019 Mar 1;278:232-237. https://doi.org/10.1016/j.ijcard.2018.10.066

97. Shimura N., Kataoka M., Inami T. et al. Additional percutaneous transluminal pulmonary angioplasty for residual or recurrent pulmonary hypertension after pulmonary endarterectomy. Int J Cardiol. 2015 Mar 15;183:138-42. https://doi.org/10.1016/j.jcard.2015.01.034

98. Brookes J.D.L., Li C., Chung S.T.W. et al. Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension: a systematic review. Ann Cardiothorac Surg. 2022 Mar;11(2):68-81. https://doi.org/10.21037/acs-2021-pte-25

99. Ishida K., Masuda M., Tanabe N. et al. Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg. 2012 Aug;144(2):321-6. https://doi.org/10.1016/j.jtcvs.2011.09.004

100. Saouti N., Morshuis W.J., Heijmen R.H., Snijder R.J. Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a single institution experience. Eur J Cardiothorac Surg. 2009 Jun;35(6):947-52; discussion 952. https://doi.org/10.1016/j.ejcts.2009.01.023

101. Shimahara Y., Suzuki S., Fujiyoshi T. et al. Balloon pulmonary angioplasty followed by pulmonary endarterectomy: Combination treatment for high-surgical-risk patients with chronic thromboembolic pulmonary hypertension. Interdiscip CardioVasc Thorac Surg 2023; https://doi.org/10.1093/icvts/ivad031

102. Madani M.M. Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: state-of-the-art 2020. Pulm Circ. 2021 May 24;11(2):20458940211007372. https://doi.org/10.1177/20458940211007372

103. Danilov N.M., Matchin Y.G., Iarovoi S.Y., et al. Balloon angioplasty as an alternative to thromboendarterectomy for proximal pulmonary artery obstruction in a patient with chronic thromboembolic pulmonary hypertension: a case report // Systemic Hypertension. 2017;14(1):41-44. (In Russ.). https://doi.org/10.26442/SG29173

104. Danilov N., Karabasheva M., Sagaydak O. Hybrid Approach For Treating Patient With Chronic Thromboembolic Pulmonary Hypertension And Extrinsic Compression Of Left Main Coronary Artery. Russian Open Medical Journal 2019. volume 8 - Issue 4. https://doi.org/10.15275/rusomj.2019.0407

105. Kajita L.J., Martinez E.E., Ambrose J.A.et al. Extrinsic compression of the left main coronary artery by a dilated pulmonary artery: clinical, angiographic, and hemodynamic determinants. Catheter Cardiovasc Interv. 2001 Jan;52(1):49-54. https://doi.org/10.1002/1522-726x(200101)52:1<49::aid-ccd1012>3.0.co;2-0

106. Sugiyama K., Koizumi N., Ogino H. Severe Compression of the Left Main Coronary Artery in a Patient with Chronic Thromboembolic Pulmonary Hypertension. Ann Thorac Cardiovasc Surg. 2018 Oct 19;24(5):251-254. https://doi.org/10.5761/atcs.cr.17-00084